Raymond S. Koff, M.D.

Dr. Koff is Professor of Medicine, University of Massachusetts Medical School, and attending physician, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, USA.

During the last three years, Dr. Koff has received grant/research support from Schering-Plough, GlaxoSmithKline and Roche. He has been a consultant to GlaxoSmithKline and has also served on the Speakers' Bureau for Roche and Schering-Plough.

Release Date: 08/01/2001
Termination Date: 08/01/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Describe the rationale for attempts to develop a HCV vaccine
• Discuss the heterogeneity of HCV and likely mechanisms of viral persistence
• Define the obstacles to HCV vaccine development.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity